Regulations are deterring research that could lead to disease treatments, say scientists.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
27 September 2017
An earlier version of this story stated that, in South Korea, gene-editing tools such as CRISPR–Cas9 cannot be used in cells that will be inserted into humans. In fact, they can be used in cells that will be inserted into the body, but under limited conditions.
References
Chung, Y. G. et al. Cell 14, 777–780 (2014).
Related links
Related links
Related links in Nature Research
Doubts raised about CRISPR gene-editing study in human embryos 2017-Aug-31
CRISPR fixes disease gene in viable human embryos 2017-Aug-02
CRISPR tweak may help gene-edited crops bypass biosafety regulation 2015-Oct-19
Stem cells made by cloning adult humans 2014-Apr-28
South Korea steps up stem-cell work 2012-May-01
Related external links
South Korea's National Bioethics CommitteeSouth Korea's National Bioethics Committee
Rights and permissions
About this article
Cite this article
Zastrow, M. South Korean researchers lobby government to lift human-embryo restrictions. Nature 549, 141 (2017). https://doi.org/10.1038/nature.2017.22585
Published:
Issue date:
DOI: https://doi.org/10.1038/nature.2017.22585
